Important note: Information in this article was accurate in 1985. The state of the art may have changed since the publication date.
THE POSSIBLE PATHOGENIC ROLE OF THE HYPERACTIVE B-LYMPHOCYTES IN AIDS
AIDS. The Epidemic of Kaposi's Sarcoma and Opportunistic Infections. Friedman-Kien AE, Laubenstein LJ, eds. New York, Masson, p. 161-8, 1984.. Unique Identifier : AIDSLINE ICDB/85610701 Zolla-Pazner S; Sidhu G; Dept. of Pathology, New York Univ. Medical Center, New York, NY; 10016
Abstract:
Hypotheses regarding B-cell hyperactivity in the Acquired Immune Deficiency Syndrome (AIDS) are discussed. B-cell hyperactivity in AIDS is suggested by an increased incidence of B-cell lymphomas; by polyclonal hypergammaglobulinemia in 90% of cases; by follicular hyperplasia; by effacement of follicular architecture in acute episodes of AIDS; by reactivation of Epstein-Barr virus, which infects B-cells; and by elevation of serum beta-2 microglobulin. In AIDS patients, the proliferative response of mononuclear cells to B-cell mitogen is suppressed to a greater degree than the corresponding responses to T-cell mitogen. From these observations, AIDS is hypothesized to be a disease of B-cells, in which B-cell hyperactivity is a primary event that causes stimulation of T-suppressor cells and subsequent depression of cellular immunity. This resembles the enhanced suppressor activity of infectious mononucleosis and of multiple myeloma. In addition, induction of suppressor cell activation has been documented in vitro and in animal models. Hypotheses arguing for T-cell aberrations as the primary event in AIDS fail to explain B-cell hyperactivity or the prevalence of B-cell lymphomas. (33 Refs)
Keywords: Acquired Immunodeficiency Syndrome/COMPLICATIONS/*IMMUNOLOGY/ PATHOLOGY Antibodies, Viral/IMMUNOLOGY B-Lymphocytes/*IMMUNOLOGY Herpesvirus 4, Human/IMMUNOLOGY Human Hypergammaglobulinemia/COMPLICATIONS Hyperplasia Infection/COMPLICATIONS Lymph Nodes/PATHOLOGY Lymphocyte Transformation Sarcoma, Kaposi's/COMPLICATIONS MEETING PAPER REVIEW
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1985. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.